Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,453 active trials24 approved drugs58 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,547 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06027892 | Two-fraction Versus Five-fraction Stereotactic Radiotherapy for Localized Prostate Cancer(SABR-Dual) | recruiting | N/A | 562 | Rabin Medical CenterOTHER | 1 | Nov 15, 2024 | clinicaltrials |
| NCT06665932 | Stereotactic Radiotherapy of Prostate Cancer With Reduction of Safety Margins | recruiting | N/A | 100 | University Hospital OstravaOTHER | 1 | Nov 12, 2024 | clinicaltrials |
| NCT06683066 | Study on Human Bioequivalence of Triprerelin Acetate for Injection | recruiting | Phase 1 | 120 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Nov 12, 2024 | clinicaltrials |
| NCT06685562 | The 4D PICTURE Project: Evaluating Metro Mapping As a Method to Support Shared Decision Making in Oncology | recruiting | — | 500 | Leiden University Medical CenterOTHER | 3 | Nov 12, 2024 | clinicaltrials |
| NCT05001477 | Customized TULSA-PRO Ablation Registry(CARE) | recruiting | — | 1,000 | Profound Medical Inc.OTHER | 1 | Nov 6, 2024 | clinicaltrials |
| NCT06579417 | ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer(ART-Pro) | recruiting | — | 500 | University of California, San DiegoOTHER | 2 | Nov 6, 2024 | clinicaltrials |
| NCT06663007 | RC48 Monotherapy or Combination With Envafolimab for CDK12 Alterations mCRPC With Standard Treatment Failure | recruiting | Phase 1 / Phase 2 | 72 | Tianjin Medical University Second HospitalOTHER | 1 | Oct 29, 2024 | clinicaltrials |
| NCT06584279 | Diagnostic Value of MRI-targeted Plus Index-lesion-ipsilaterally Systematic Biopsy for Biopsy-naive Men At Risk of Prostate Cancer | recruiting | — | 563 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Oct 24, 2024 | clinicaltrials |
| NCT06617481 | PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence | recruiting | Phase 2 | 30 | AdventHealthOTHER | 1 | Oct 24, 2024 | clinicaltrials |
| NCT06655259 | Combination of TURP and Standard Systemic Therapy for MPCa(CTUSMEP01) | recruiting | Phase 2 | 200 | Fudan UniversityOTHER | 1 | Oct 23, 2024 | clinicaltrials |
| NCT05558007 | Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients | recruiting | Phase 2 | 72 | Biozeus Biopharmaceutical S.A.INDUSTRY | 1 | Oct 22, 2024 | clinicaltrials |
| NCT06636682 | FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer | recruiting | Phase 2 | 100 | Cellvax Therapeutics IncINDUSTRY | 1 | Oct 21, 2024 | clinicaltrials |
| NCT05629494 | Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test(ADAPT-PSA) | recruiting | Phase 4 | 198 | Albany Medical CollegeOTHER | 1 | Oct 18, 2024 | clinicaltrials |
| NCT06274892 | Remote Monitoring of Patient Reported Outcomes to Improve the Efficacy of the Acute Phase Radiotherapy Review Process(PROMOTE) | recruiting | N/A | 124 | University Health Network, TorontoOTHER | 1 | Oct 17, 2024 | clinicaltrials |
| NCT06636747 | High Resolution Diffusion Weighted Imaging in Prostate | recruiting | — | 500 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT06637267 | Prospective Evaluation of Proclarix® Test to Improve Risk Stratification in Men Scheduled for MpMRI and Prostate Biopsy in Cantonal Hospital Aarau | recruiting | — | 480 | Kantonsspital AarauOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT05129605 | Prostate Cancer Genetic Risk Evaluation and Screening Study(PROGRESS) | recruiting | — | 400 | Massachusetts General HospitalOTHER | 1 | Oct 9, 2024 | clinicaltrials |
| NCT06630962 | Evaluating the Impact of Financial Navigation on Financial Catastrophe and Distress for Cancer Care(COST-FIN) | recruiting | N/A | 200 | Northwestern UniversityOTHER | 1 | Oct 8, 2024 | clinicaltrials |
| NCT06626386 | Determination of Prostate-specific Antigen in Capillary Blood (PSA-Cap)(PSA-Cap) | recruiting | — | 200 | Heinrich-Heine University, DuesseldorfOTHER | 1 | Oct 3, 2024 | clinicaltrials |
| NCT06071195 | All-in-One Prostate Cancer Staging with MRI(AllinOne_MRI) | recruiting | — | 400 | European Institute of OncologyOTHER | 1 | Sep 27, 2024 | clinicaltrials |
| NCT06612580 | 68Ga-AAZTA-NI-093 PET/CT: First-in-human Study | recruiting | Early Phase 1 | 10 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | Sep 25, 2024 | clinicaltrials |
| NCT05100121 | To Live Better After Prostate Cancer Treatment:(CAPPRIS) | recruiting | N/A | 40 | Karolinska InstitutetOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05613023 | A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT(PACE-NODES) | recruiting | Phase 3 | 1,128 | Institute of Cancer Research, United KingdomOTHER | 3 | Sep 19, 2024 | clinicaltrials |
| NCT06184464 | Prostatic Size Reduction Following of Leuprorelin Acetate(PROSTSIZE) | recruiting | — | 40 | Consorci Sanitari de TerrassaOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06521710 | Nerve Grafting Technique to Preserve Erectile Function in Patients Undergoing Robotic Assisted Radical Prostatectomy(NR-RALP) | recruiting | N/A | 10 | Sir Mortimer B. Davis - Jewish General HospitalOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06585007 | Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer(MEDCARE) | recruiting | Phase 3 | 246 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Sep 5, 2024 | clinicaltrials |
| NCT05714774 | Evaluation of Different Methods of Ultrasound Image Analysis for Real-time Monitoring of HIFU Prostate Cancer Treatment(ELASTO-US) | recruiting | N/A | 40 | Hospices Civils de LyonOTHER | 1 | Sep 4, 2024 | clinicaltrials |
| NCT06575257 | Neoadjuvant Therapy of Darolutamide Plus ADT for High Risk Prostate Cancer | recruiting | Phase 2 | 80 | Xijing HospitalOTHER | 1 | Aug 28, 2024 | clinicaltrials |
| NCT06279260 | National Robotics-Assisted Radical Prostatectomy Database(RASOR) | recruiting | — | 10,000 | Melbourne HealthOTHER | 1 | Aug 26, 2024 | clinicaltrials |
| NCT06325774 | Radical Hypofractionated Radiotherapy for Localized Prostate Cancer | recruiting | N/A | 20 | Changhai HospitalOTHER | 1 | Aug 26, 2024 | clinicaltrials |
| NCT06325995 | Hypofractionated Post-prostatectomy Radiotherapy (HYPORT)for Localized Prostate Cancer | recruiting | N/A | 428 | Changhai HospitalOTHER | 1 | Aug 26, 2024 | clinicaltrials |
| NCT06362577 | Clinical Study of HIFU for Localized Prostate Cancer(HIFU) | recruiting | — | 60 | RenJi HospitalOTHER | 1 | Aug 15, 2024 | clinicaltrials |
| NCT06343038 | Targeted Radionuclide Therapy in Metastatic Prostate Cancer Using a New PSMA Ligand Radiolabelled With Terbium-161 (161Tb-SibuDAB) - Dose Identification/Escalation Phase Ia/b Study(PROGNOSTICS) | recruiting | Phase 1 | 25 | University Hospital, Basel, SwitzerlandOTHER | 1 | Aug 14, 2024 | clinicaltrials |
| NCT06529549 | Efficacy and Safety of Organoid-Based Drug Sensitivity Screening to Guide the Treatment of mCRPC Patients Progressed After First-line Treatment | recruiting | — | 30 | Sun Yat-sen UniversityOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT06518226 | Two-Fraction Ultrahypofractionated Radiotherapy With Focal Boost for Intermediate Risk, Localized Prostate Cancer(TURBO) | recruiting | N/A | 160 | UMC UtrechtOTHER | 1 | Jul 24, 2024 | clinicaltrials |
| NCT06494696 | 68Ga-PSMA PET/MRI in Conjunction With mpMRI for Evaluating Prospective Prostate Cancer Risk | recruiting | — | 71 | Chang Gung Memorial HospitalOTHER | 1 | Jul 10, 2024 | clinicaltrials |
| NCT06491056 | Prospective Asian Multicenter Prostate Cancer Focal Therapy Study (ProAMFocal)(ProAMFocal) | recruiting | — | 500 | Singapore General HospitalOTHER | 1 | Jul 8, 2024 | clinicaltrials |
| NCT05549024 | 68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients | recruiting | Early Phase 1 | 90 | Peking Union Medical College HospitalOTHER | 1 | Jul 5, 2024 | clinicaltrials |
| NCT05352178 | Metastasis-directed Therapy for Oligorecurrent Prostate Cancer(SPARKLE) | recruiting | Phase 3 | 873 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT06449664 | Training for Men Undergoing Androgen Deprivation Therapy.(ADT-train) | recruiting | N/A | 60 | The Swedish School of Sport and Health SciencesOTHER | 1 | Jun 10, 2024 | clinicaltrials |
| NCT06423976 | Microbiome Molecular Charaterisation(MMC) | recruiting | — | 1,000 | Institute of Cancer Research, United KingdomOTHER | 1 | May 24, 2024 | clinicaltrials |
| NCT04694924 | Prospective Prostate Cancer and Patient-reported Outcomes Registry(Prosquare) | recruiting | — | 5,000 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT05539677 | Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research(REGATA) | recruiting | — | 1,000 | N.N. Petrov National Medical Research Center of OncologyOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT06397755 | Observational Study of Patients Who Underwent Diagnostic Investigation (Prostate Biopsy) and/or Radical Prostatectomy Surgery. | recruiting | — | 20,000 | IRCCS San RaffaeleOTHER | 1 | May 3, 2024 | clinicaltrials |
| NCT06357416 | The Man Van Project(MV) | recruiting | N/A | 4,000 | Royal Marsden NHS Foundation TrustOTHER | 1 | May 1, 2024 | clinicaltrials |
| NCT06387056 | Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)(SEGNO) | recruiting | Phase 2 | 40 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| NCT04838899 | Stereotactic Ablative Radiation Therapy for Abiraterone-Resistant, Oligoprogressive Metastatic Prostate Cancer | recruiting | N/A | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT06350825 | Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients | recruiting | Phase 3 | 200 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Apr 5, 2024 | clinicaltrials |
| NCT06335693 | Adjuvant Hypofractionated Radiotherapy for Prostate Cancer | recruiting | N/A | 9 | Changhai HospitalOTHER | 1 | Mar 28, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Nov 15, 2024source: clinicaltrials